The international pharmaceutical company has developed and researched this new drug in 9 different countries worldwide. In the third research phase, more than 2500 people participated and weighed about 105 kg.
These individuals were divided into four groups; one group was given 5 mg of the drug once a week by injection.
The second group was given 10 mg of the drug per week, and the third group was assigned 15 mg per week.
While the fourth group was given a counterfeit drug, it is essential to note that this counterfeit drug was not harmful to health at all.
The company hopes that, based on research findings, the Central American Food and Drug Administration will approve the drug as an anti-obesity drug.
All participants in the study were instructed to take care of their diet and exercise, which lasted for about a year and five months.
When the trial was completed, revolutionary results emerged, with the group taking the counterfeit drug losing only 2.4% of its weight.
Only 5 mg per week weighed 16% of the group taking the new drug, while 15 mg per week reduced the group’s weight by taking 22.5%.